Pfizer and BioNTech ramp up COVID-19 vaccine production to 2.5 billion doses

Pfizer and BioNTech expect to expand COVID-19 vaccine manufacturing capacity to up to 2.5 billion doses by the end of 2021, thanks to the optimization of production processes and the recent initiation of production in Marburg, Germany.